AIGH Capital Management’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,082,491
Closed -$4.91M 52
2025
Q2
$4.91M Sell
2,082,491
-244,078
-10% -$598K 2.21% 18
2025
Q1
$3.26M Sell
2,326,569
-700,000
-23% -$1.17M 1.35% 25
2024
Q4
$5.48M Sell
3,026,569
-698,635
-19% -$950K 1.71% 22
2024
Q3
$4.61M Hold
3,725,204
1.3% 20
2024
Q2
$5.23M Hold
3,725,204
1.63% 18
2024
Q1
$6.16M Buy
3,725,204
+5,902
+0.2% +$9.47K 1.85% 16
2023
Q4
$6.03M Buy
3,719,302
+2,915,906
+363% +$4.39M 2.38% 15
2023
Q3
$1.73M Buy
+803,396
New +$1.72M 0.82% 34

Other funds holding THTX

AIGH Capital Management's THTX Position: Q3 2025 in Review

AIGH Capital Management sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 2,082,491 shares — an estimated $4.91M sold.

AIGH Capital Management first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $6.16M in Q1 2024. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • AIGH Capital Management reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • AIGH Capital Management sold 2,082,491 Theratechnologies shares in Q3 2025, an estimated $4.91M.
  • AIGH Capital Management first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • AIGH Capital Management's Theratechnologies position peaked at $6.16M in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on AIGH Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.